Supplemental material
Open access
3,840
Views
5
CrossRef citations to date
0
Altmetric
Research Article
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial
Jacob P. Thyssena Department of Dermatology and Venersology, Bispebjerg Hospital, Copenhagen, DenmarkView further author information
, Thomas Werfelb Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, GermanyView further author information
, Sebastien Barbarotc Department of Dermatology, Nantes Université, Centre Hospitalier Universitaire de Nantes, Nantes, FranceView further author information
, Hamish J.A Hunterd Department of Dermatology, Salford Care Organisation, part of the Northern Care Alliance NHS Foundation Trust, Salford, UKView further author information
, Evangeline Piercee Eli Lilly and Company, Indianapolis, IN, USAView further author information
, Luna Sune Eli Lilly and Company, Indianapolis, IN, USAView further author information
, Lisa Cirrie Eli Lilly and Company, Indianapolis, IN, USAView further author information
, Andrew S. Buchanane Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
View further author information
, View further author information
Na Luf Precision Statistics Consulting, Woodbury, MN, USAView further author information
& Andreas Wollenbergg Department of Dermatology and Allergy, University Hospital, Ludwig Maximillian University, Munich, GermanyView further author information
show all
Article: 2190430
|
Received 13 Dec 2022, Accepted 09 Mar 2023, Published online: 05 Apr 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.